Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
10
Frequently Asked Questions
What is Market Cap of Processa Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Processa Pharmaceuticals Inc market cap is $8.65M.
What is the 52-week high for Processa Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Processa Pharmaceuticals Inc 52 week high is $1.50 as of September 07, 2025.
What is the 52-week low for Processa Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Processa Pharmaceuticals Inc 52 week low is $0.15 as of September 07, 2025.
What is Processa Pharmaceuticals Inc stock price today?
Processa Pharmaceuticals Inc stock price today is $0.1718.
What was Processa Pharmaceuticals Inc stock price yesterday?
Processa Pharmaceuticals Inc stock price yesterday was $0.1697.
What is the PE ratio of Processa Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Processa Pharmaceuticals Inc’s P/E ratio is -0.07.
What is the Price-to-Book ratio of Processa Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Processa Pharmaceuticals Inc P/B ratio is 1.1332.
What is the 50-day moving average of Processa Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Processa Pharmaceuticals Inc 50-day moving average is $0.2158.
How many employess does Processa Pharmaceuticals Inc has?
